Study to Explore the Mechanism of Acquired Immune Escape In Participants With Metastatic Cancer Progressing on CPI Therapy
Clinical trial NCT03333655 · COMPLETED
Trial details
- NCT number
- NCT03333655
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-16
- Primary completion
- 2022-08-04
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.